Northern Trust
DAWN

Northern Trust’s Day One Biopharmaceuticals DAWN Stock Holding History

Northern Trust’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.3M Buy
666,180
+49,145
+8% +$692K ﹤0.01% 1877
2025
Q4 		$5.75M Sell
617,035
-12,557
-2% -$105K ﹤0.01% 2389
2025
Q3 		$4.44M Buy
629,592
+18,431
+3% +$127K ﹤0.01% 2568
2025
Q2 		$3.97M Buy
611,161
+75,164
+14% +$517K ﹤0.01% 2593
2025
Q1 		$4.25M Sell
535,997
-11,053
-2% -$119K ﹤0.01% 2507
2024
Q4 		$6.93M Buy
547,050
+51,960
+10% +$723K ﹤0.01% 2330
2024
Q3 		$6.9M Sell
495,090
-37,949
-7% -$541K ﹤0.01% 2290
2024
Q2 		$7.35M Sell
533,039
-25,106
-4% -$367K ﹤0.01% 2177
2024
Q1 		$9.22M Sell
558,145
-18,607
-3% -$278K ﹤0.01% 2086
2023
Q4 		$8.42M Buy
576,752
+24,898
+5% +$302K ﹤0.01% 2177
2023
Q3 		$6.77M Buy
551,854
+119,262
+28% +$1.56M ﹤0.01% 2256
2023
Q2 		$5.17M Buy
432,592
+213,071
+97% +$2.78M ﹤0.01% 2479
2023
Q1 		$2.93M Sell
219,521
-5,748
-3% -$112K ﹤0.01% 2763
2022
Q4 		$4.85M Buy
225,269
+219
+0.1% +$4.49K ﹤0.01% 2509
2022
Q3 		$4.51M Buy
225,050
+34,540
+18% +$735K ﹤0.01% 2554
2022
Q2 		$3.41M Buy
190,510
+20,211
+12% +$209K ﹤0.01% 2756
2022
Q1 		$1.69M Buy
170,299
+66,622
+64% +$880K ﹤0.01% 3179
2021
Q4 		$1.75M Buy
103,677
+5,578
+6% +$115K ﹤0.01% 3288
2021
Q3 		$2.33M Buy
98,099
+85,381
+671% +$2.05M ﹤0.01% 3208
2021
Q2 		$290K Buy
+12,718
New +$265K ﹤0.01% 3956

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Northern Trust's DAWN Position: Q1 2026 in Review

Northern Trust increased its Day One Biopharmaceuticals (DAWN) stake by 8% in Q1 2026, buying an estimated $692K and bringing the position to 666,180 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1877.

Northern Trust first reported a position in DAWN in Q2 2021 and has held it in 20 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Northern Trust held 666,180 shares of Day One Biopharmaceuticals worth $14.3M as of Q1 2026.
  • Northern Trust bought 49,145 Day One Biopharmaceuticals shares in Q1 2026, an estimated $692K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1877 holding.
  • Northern Trust first reported a position in Day One Biopharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.